A Prospective, Multicenter, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Preoperative Antithrombin Supplement in Patients Undergoing High Risk Cardiac Surgery with Cardiopulmonary Bypass